and biological carcinogens are external agents that have been extensively linked to cancer. However, the single most important risk factor for cancer is tobacco use, which causes one out of five global cancer deaths and nearly 70% of global lung cancer deaths (Cohen et al., 2017; Torre et al., 2015) . Despite the various treatment modalities available, the problem of poor selectivity and severe side effects of the available anticancer drugs have limited cancer chemotherapy success. This situation is complicated by the emergence and spread of multidrug resistance in cancer cells, which occurs through several mechanisms, such as the p53 tumour suppressor genes mutations (Li et al., 2014) , overexpression of ABC transporters (Kalapos-Kovács et al., 2015) , and the epidermal growth factor receptor (Safe & Kasiappan, 2016) . These factors have necessitated the need for the search and development of safer and more effective chemotherapeutic agents.
Natural products have been used from earliest times for the treatment of many ailments. Approximately 70% of the drugs used today are models of natural products. In addition, secondary metabolites derived from natural products are the most successful source of potential drug leads (Newman & Cragg, 2016; Rey-Ladino, Ross, Cripps, McManus, & Quinn, 2011) . Over the past five decades, many medicinal plants have been screened for cytotoxicity. Although Africa hosts 57,704 species of the world's flora and Africans utilize about 5,000 plants for medicinal purposes (Tariq et al., 2017) , the discovery of anticancer drug leads from African medicinal plants has not been fully realized as plants from Chinese herbal medicine. For instance, camptothecin, a cytotoxic alkaloid that inhibits DNA topoisomerase I, was isolated from the bark of Camptotheca acuminata, a plant used for the treatment of cancer in traditional Chinese medicine. Homoharringtonine, from Cephalotaxus harringtonia var. drupacea, is a cytotoxic agent in clinical use discovered from traditional Chinese medicine (Newman & Cragg, 2016) . Recently, some African countries have begun to make a commitment to discover bioactive drug leads from indigenous medicinal plants. The recent screening of 7,500 species of medicinal plants from South Africa for anticancer activity (Fouche et al., 2008) and various investigative work by scientists in Nigeria (Ashidi, Houghton, Hylands, & Efferth, 2010; Engel, Oppermann, Falodun, & Kragl, 2011; Fadeyi, Fadeyi, Adejumo, Okoro, & Myles, 2013; Ogbole, Segun, & Adeniji, 2017; Segun, Ismail, et al., 2018; attests to this claim.
In the present report, the continuous search of potential antiproliferative agents from the Nigerian flora was extended to Commiphora africana (A. Rich.) Endl. (Burseraceae). This plant is a tree of not more than 5 m high found in dry sites and savannah forest of Africa. The tree has a short trunk with a creeping root system that spreads several metres around the tree (Aliyu, Adebayo, & Garba, 2007) . The leaves of C. africana are used traditionally to treat menstrual pains, painful swellings, and wounds (Adebayo, Aliyu, Gatsing, & Garba, 2006) .
Typical of the genus Commiphora, the tree produces a resinous gum, which is used medicinally to seal and disinfect wounds. The fruits are used for the treatment of abdominal cramps and typhoid infection (Ezekiel et al., 2010) . Previous biological investigations revealed that the plant possesses antilipidemic, anti-inflammatory, antioxidative, anthelmintic and antimicrobial activities (Adebayo et al., 2006; Compaoré, Meda, Bakasso, Vlase, & Kiendrebeogo, 2016; Gbolade & Adeyemi, 2008 ). Aliyu and co-workers reported that the ethanol leaf extract of C. africana may enhance liver and kidney function at low doses but may elicit toxic effects on these organs at high concentration (Aliyu et al., 2007) . The hydro-ethanolic extract of the stem bark of the plant was shown to demonstrate anticonvulsive activity and possess the ability to regulate sleep disorders in mice (Ezekiel et al., 2010) . Phellamurin 1, a dihydroflavonol glucoside isolated from the dichloromethane-methanol extract of C. africana, mediated Cu 2+ -dependent relaxation of supercoiled plasmid DNA (Ma, Jones, & Hecht, 2005) . Recently, we conducted an ethnobotanical study of medicinal plants used for the management of cancer in local communities of south-western Nigeria. Our findings revealed that C. africana was one of the most frequently used medicinal plants for the treatment of cancer. Other recent ethnobotanical surveys from the northern part of Nigeria also documented the use of the stem bark of the plant for the treatment of cancer (Dafam et al., 2016; Ngulde, Sandabe, & Hussaini, 2015) . Therefore, the present study was designed to investigate the cytotoxicity of the methanol (MeOH) extract of the stem bark of C. africana, its solid-phase extraction (SPE) and fractions and isolated compounds against four human carcinoma cell lines: the breast (MCF7), the liver (HepG2), the lung (A549), the prostate (PC3), and the immortalized human prostatic epithelial cells (PNT-2) using the in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazoliumbromide (MTT) viability assay. 
| Extraction and isolation of active compounds
The powdered dried bark of C. africana (170 g each) was extracted using a Soxhlet apparatus with 800 ml each of n-hexane, dichloromethane, and methanol (MeOH). To ensure exhaustive extraction, 10 cycles were allowed for each extraction and the heating mantle was kept constant at 50°C for all extractions. Filtered extracts were concentrated and dried using a rotary evaporator at 40°C and stored in the refrigerator prior to use. A Strata C-18 cartridge (35 μm; 70 Å; 20 g) was washed with MeOH (50 ml) followed by equilibration with HPLC grade water (100 ml). The dried MeOH extract (2 g) was dissolved in 10 ml of HPLC grade water and loaded on to the cartridge (Basar et al., 2015) . The cartridge was eluted with a binary gradient solvent system to obtain four fractions: 20%, 50%, 80%, and 100%
MeOH in water (250 ml each), coded respectively as CAF1, CAF2, CAF3, and CAF4. All four fractions were evaporated to dryness and stored in the refrigerator prior to cytotoxic screening. CAF2 and CAF3, which were the most active against the cancer cell lines under investigation, were further purified as described below. CAF2 ( 
| Preparation of extracts and compounds
Plant extracts and fractions were dissolved in 10% dimethyl sulfoxide (DMSO), to give a stock solution (SS) of 100 mg/ml. Vortex agitation was used to ensure the uniformity of the solution prior to use. From the SS, serial dilutions were made in the cell culture media to obtain working concentrations of 100, 20, 4, 0.8, and 0.16 μg/ml. For the pure compounds, an SS of 1 M was prepared; thereafter, serial dilutions were made to give working concentrations of 100, 50, 25, 12.5, and 6.25 μM for treatment with MCF7, HepG2, A549, and PC3 and working concentrations of 800, 400, 200, 100, and 50 μM for treatment with PNT2. For vinblastine (positive control), an SS of 10 μM was prepared; thereafter, serial dilutions were made to give working concentrations of 100, 50, 25, 12.5, and 6.25 nM. Dilutions of the SS were made in cell culture media, with the final concentration of DMSO not exceeding 0.1%, which had previously been found not to be cytotoxic (Basar et al., 2015) .
| Colorimetric MTT in vitro assay
Cytotoxicity testing was carried out using the MTT assay, which determines the number of viable cells in culture (Gerlier & Thomasset, 1986) . After repeated initial experiments, the cell densities for optimal growth were found to be 2 × 10 4 , 4 × 10 fraction/compound to be tested, whereas the last well (A6)
contained only 1 ml of the DMSO growth medium (negative control).
The experiment was conducted in quadruplicate for each test dilutions, so that wells A1-D1, A2-D2, A3-D3, A4-D4, and A5-D5 contained different concentrations of the extract/fraction/compound. At the expiration of the incubation period, the MTT assay was performed to measure the cell viability. The protocol described earlier in the literature was adopted with slight modifications (Mosmann, 1983) . Briefly, the old medium was removed from each well by vacuum suctioning and replaced with 1 ml of 500-μg/ml MTT dye in PBS. The plates were incubated for 2 hr at 37°C/5% CO 2 to allow the production of formazan crystals. After incubation, the medium was removed by vacuum suctioning and 500 μL of propanol was added under light protection to dissolve the dark blue formazan crystals. The plates were placed on a shaker for 10 min to enhance the dissolution of preformed formazan crystals. The dilutions in each 24-well plate were transferred into a 96-well plate so that the solution in A1 (24-well) was transferred to A1-A4 (96-well), B1 (24-well) was transferred to B1-B4 (96-well), and so on. The absorbance of the solution was measured at 570 nm on a Clario Star microplate reader. The average optical density (OD) obtained from the negative control wells was set arbitrarily at 100%, and the average OD of treatment wells was calculated relative to the negative control. In addition, the same process was carried out for vinblastine (positive control) using the concentration range mentioned above.
To obtain the selectivity indices (SI) of the isolated compounds, the normal PNT2 cell line was used. The SI value was calculated as the ratio of the IC 50 values of the compounds on PNT2 cells relative to those in the cancer cell lines.
Two sets of 24-well plates were used to determine whether the antiproliferative activities of compounds 1-3 were cytostatic or cytocidal. The first plate measured the cell growth inhibition after 72-hr treatment (exposure assay), whereas the second plate determined the cell growth inhibition after a further 72-hr period, following replacement of the old medium containing the test compound with fresh growth medium alone (recovery assay; Ashidi et al., 2010) . The antiproliferative effect is cytostatic when the IC 50 value of the recovery assay is higher than that of the exposure assay, whereas the effect is cytocidal when the IC 50 value is similar in both recovery and exposure assay (Wong, Abdul Kadir, & Ling, 2011 ).
| Statistical analysis
The results obtained were expressed as mean ± standard error of mean. The experiments were conducted in quadruplicate on three different occasions. The cell viability was calculated as
The statistical analysis was done using GraphPad (Version 5.01, GraphPad Prism Software Inc., San Diego, CA,). One-way analysis of variance followed by Tukey's test (each treatment compared with control) was used to test for the statistical differences between the groups. Differences between means were considered statistically significant when P < 0.05. IC 50 values were obtained from graphs plotted using non-linear regression equation log (inhibitor) versus response − variable slope.
| RESULTS AND DISCUSSION

| Structure determination
As the MeOH fraction of C. africana displayed significant cytotoxicity against several cell lines, it was fractionated into four parts using the SPE. The isolated compounds from the active CAF2 and CAF3
were identified as (E)-resveratrol 3-O-rutinoside (1), 5-methoxy-(E)-resveratrol 3-O-rutinoside (2), pinostilbene (3), and 3-hydroxy-5-methoxybenzoic acid (4; Figure 1 ) by direct comparison of their spec- 105.6 (C-4), 160.9 (C-5), 108.9 (C-6), and 168.4 (C-7).
| Cytotoxicity assay
Soxhlet extraction of the stem bark of C. africana (290 g) led-after evaporation under vacuum-to n-hexane extract (4.14 g; 1.3% yield), DCM extract (1.36 g; 0.5% yield), and MeOH extract (16.5 g; 5.7% yield). These extracts were tested against MCF7 (breast), HepG2
(liver), A549 (lung), and PC3 (prostate) carcinoma cells according to the MTT assay, and the cytotoxicity result is reported in Table 1 . The cell lines used in this study were selected because of high incidence rate for these cancers and the need to develop effective and safe medications for treatment. For example, breast cancer is the most common form of cancer in female, whereas prostate cancer is the most diagnosed cancer type in male. Furthermore, lung cancer was the most common cause of cancer deaths globally, accounting for 18.2% (1.7 million deaths) of the total cancer mortality in 2015 (Fitzmaurice et al., 2017) . The n-hexane extract showed no antiproliferative activity at the highest concentration used in this study, whereas the DCM extract displayed cytotoxicity with IC 50 values of 62.63, 61.92, 63.88, and 68 .21 μg/ml against MCF7, A549, PC3, and HepG2, respectively. However, the MeOH fraction showed the highest cytotoxicity amongst the extracts, with IC 50 values of 12.14, 12.28, 14.95, and 16.15 μg/ml against MCF7, A549, PC3, and HepG2, respectively. As the cytotoxicity displayed by the MeOH extract of C. africana met the specification of the National Cancer Institute (NCI), which requires a crude plant extract to display IC 50 value <30 μg/ml before it could be considered as active (Rajkapoor et al., 2007) , it was selected for fractionation by the SPE method. The screening of the SPE fractions on the cancer cells using the MTT assay
showed that CAF2 and CAF3 displayed the highest cytotoxicity across the panel of carcinoma cells (Table 1) . Purification of CAF2 and In order to gain an insight into the mechanism of the cytotoxicity displayed by the isolated compounds, it was necessary to determine whether the antiproliferative effect were due to cytostatic effects or cytocidal effects. It was observed that with the exception of the shrimp larvae at concentrations of up to 1,000 ppm (Wanjala & Majinda, 2001 ). An earlier study reported that 5-methoxy-(E)-resveratrol 3-O-rutinoside regulated angiogenesis by decreasing the activity of proangiogenic FGF-2 and also inhibited in vivo angiogenesis in the chick chorioallantoic membrane assay (Hussain et al., 2009 ). Recent research showed that pinostilbene significantly inhibited the proliferation of human colon cancer cells (HCT116 and HT29), causing cell cycle arrest at the S phase, leading to the induction of apoptosis (Sun et al., 2016) . Another study revealed that pinostilbene displayed in vitro cytotoxicity with IC 50 value of 78.13 μM against NCI-H187
FIGURE 2
Graphs showing the effect of the test compounds on the viability of MCF7, A549, PC3, and HepG2. The cells were treated with various concentration of compounds for 72 hr, and the viability was measured using MTT assay. Vinblastine was used as the positive standard, with IC 50 of 21-37 nM across the panel of carcinoma cells. According to the IC 50 value, the rank order of increasing potencies of the compounds is (E)-resveratrol 3-O-rutinoside (1) > 5-methoxy-(E)-resveratrol 3-O-rutinoside > pinostilbene (3). Values shown are means ± standard error of the mean of three different experiments. **P < 0.01 and ***P < 0.001, compared with the negative control (dimethyl sulfoxide only), evaluated using the Tukey multiple comparison. X-axis: concentration in μM FIGURE 3 Graphs comparing the IC 50 value of the exposure (E) and recovery assay (R) following the treatment of MCF7, A549, PC3, and HepG2 with various concentrations of the test compounds. Exposure assay measures cell growth inhibition after 72-hr treatment, whereas the recovery assay measures the cell growth inhibition, following replacement of the old medium containing the test compound with fresh growth medium alone for a further 72 hr. Vinblastine was used as the positive standard and reference compound. With the exception of the HepG2 cells, the test compounds displayed cytocidal effects on the cancer cell lines as the IC 50 value in the exposure assay was greater than or equal to those recorded in the recovery assay. Values shown are means ± standard error of the mean of three different experiments. **P < 0.01 and ***P < 0.001, compared with the exposure assay, evaluated using the Student's t-test. X-axis: concentration in μM cell line (Lertnitikul et al., 2016) . Pinostilbene was shown to possess high antioxidant capacity displaying a value of 5.01 Trolox equivalents/μM in an oxygen radical absorbance capacity assay (Uesugi et al., 2017) . The antioxidant capacity could have been contributed to the cytotoxicity of pinostilbene, reported in the present study.
To the best of our knowledge, this is the first report on the cytotoxicity of the MeOH extract of the stem bark of C. africana, and its (Shen et al., 2012) . Similarly, erlangerin A to D, lignans isolated from the resins of Commiphora erlangeriana were shown to display cell growth inhibitory activity on two human (HeLa and EAhy926) and two murine (L929 and RAW 264.7) cell lines (Habtemariam, 2003) .
| CONCLUSION
In this study, we report the antiproliferative potentials of the extracts and isolated compounds of C. africana on four human carcinoma cells.
These results validate the folklore use of C. africana in the treatment of cancer. 
